Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists and the kidney.

M Chellingsworth1, M J Kendall

  • 1Department of Therapeutics and Clinical Pharmacology, Medical School, University of Birmingham, UK.

Journal of Human Hypertension
|June 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charles Dickens' favourite child and a new kind of ray.

Journal of clinical pharmacy and therapeutics·2016
Same author

Experimentally simulating high-rate behaviour: rate and temperature effects in polycarbonate and PMMA.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2014
Same author

Mechanics of particulate composites with glassy polymer binders in compression.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2014
Same author

Availability of methaqualone from commercial preparations: in vitro and in vivo studies in man.

British journal of clinical pharmacology·2012
Same author

An assessment of gastric emptying by breathalyser.

British journal of clinical pharmacology·2012
Same author

The influence of diphenhydramine on the absorption of methaqualone in man.

British journal of clinical pharmacology·2012
Same journal

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps.

Journal of human hypertension·2026
Same journal

Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.

Journal of human hypertension·2026
Same journal

Invasive observation of reactive systolic blood pressure responses to upper-arm cuff inflation.

Journal of human hypertension·2026
Same journal

Association between post-thrombectomy blood pressure trajectories and clinical outcomes in hypertensive patients with acute ischemic stroke: a retrospective cohort study.

Journal of human hypertension·2026
Same journal

Systemic inflammation indices generated from first-trimester blood tests can be potential biomarkers for predicting preeclampsia.

Journal of human hypertension·2026
Same journal

Chronotherapy in hypertension: a systematic review and meta-analysis of antihypertensive dosing timing on cardiovascular outcomes.

Journal of human hypertension·2026
See all related articles

Calcium antagonists are safe for patients with kidney issues and heart disease. These drugs help manage hypertension and ischemic heart conditions, even with impaired renal function.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Calcium antagonists are widely prescribed for hypertension and ischemic heart disease.
  • Patients with these conditions frequently exhibit renal impairment, necessitating an understanding of drug effects on the kidney.
  • The impact of calcium antagonists on renal function in patients with renal impairment is a critical clinical consideration.

Purpose of the Study:

  • To investigate the effects of calcium antagonists on renal haemodynamics and function in patients with renal impairment.
  • To explore the mechanisms behind the natriuretic and diuretic effects of calcium antagonists.
  • To assess the safety and utility of calcium antagonists in patients with co-existing hypertension or ischemic heart disease and renal impairment.

Main Methods:

Related Experiment Videos

  • Review of existing literature on calcium antagonist use in patients with renal impairment.
  • Analysis of studies examining renal haemodynamics and function in response to calcium antagonists.
  • Pharmacokinetic evaluation of calcium antagonists in patients with varying degrees of renal failure.

Main Results:

  • Calcium antagonist effects on renal haemodynamics are variable, dose-dependent, and influenced by patient status.
  • Calcium antagonists induce natriuresis and diuresis through incompletely understood mechanisms, potentially independent of direct renal haemodynamic effects.
  • The diuretic effect may mitigate edema associated with vasodilator therapy.
  • Peripheral renin activity responses are unpredictable, influenced by direct and haemodynamic factors.
  • Calcium antagonist pharmacokinetics are largely unaffected by renal failure due to hepatic metabolism.

Conclusions:

  • Calcium antagonists demonstrate safety and utility in treating hypertension and ischemic heart disease in patients with renal impairment.
  • Understanding the variable renal effects is crucial for optimizing therapy.
  • Further research into the precise mechanisms of diuretic and natriuretic effects is warranted.